220 related articles for article (PubMed ID: 36046761)
21. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
Han W; Weng K; Zhang P; Hong Z
Front Surg; 2022; 9():1091601. PubMed ID: 36684142
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Wang Y; Zhou H; Zhong G; Fu Z; Peng Y; Yao T
Clin Appl Thromb Hemost; 2022; 28():10760296221095558. PubMed ID: 35549519
[TBL] [Abstract][Full Text] [Related]
25. Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.
Huang Z; Li L; Gong Z; Tang L
Clin Appl Thromb Hemost; 2024; 30():10760296241255958. PubMed ID: 38767088
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
27. [Retrospective Analysis of Risk Factors for Venous Thromboembolism in 283 Patients with Lung Cancer during Systemic Therapy].
Liu Y; Gu Y; Yi F; Cao B
Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):419-426. PubMed ID: 31315780
[TBL] [Abstract][Full Text] [Related]
28. Risk Factor Analysis of Postoperative Venous Thromboembolism in Patients After Thoracoscopic Lobectomy.
Qiao J; Feng J; Hu W; Wu Y
Clin Appl Thromb Hemost; 2023; 29():10760296231156908. PubMed ID: 36775882
[TBL] [Abstract][Full Text] [Related]
29. Establishment and Validation of a Postoperative VTE Prediction Model in Patients with Colorectal Cancer Undergoing Radical Resection: CRSPOT Nomogram.
Wu Y; Wang L; Yin Q; Deng L; Ma J; Tian X
Clin Appl Thromb Hemost; 2023; 29():10760296231216966. PubMed ID: 37997283
[TBL] [Abstract][Full Text] [Related]
30. Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model.
Di W; Xu H; Ling C; Xue T
Thromb J; 2023 Sep; 21(1):95. PubMed ID: 37710256
[TBL] [Abstract][Full Text] [Related]
31. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
[TBL] [Abstract][Full Text] [Related]
32. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
33. Postoperative venous thromboembolism after surgery for stage IA non-small-cell lung cancer: A single-center, prospective cohort study.
Dong H; Liang X; Gao Y; Cai Y; Li X; Miao J; Wang W; Hu B; Li H
Thorac Cancer; 2022 May; 13(9):1258-1266. PubMed ID: 35315227
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a nomogram model for predicting the risk of venous thromboembolism in lymphoma patients undergoing chemotherapy: a prospective cohort study conducted in China.
Liang G; Li X; Xu Q; Yang Z; Li J; Yang T; Wang G; Lei H
Ann Med; 2023; 55(2):2275665. PubMed ID: 38132496
[TBL] [Abstract][Full Text] [Related]
35. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
[TBL] [Abstract][Full Text] [Related]
36. Risk factor analysis and a new prediction model of venous thromboembolism after pancreaticoduodenectomy.
Yin ZJ; Huang YJ; Chen QL
BMC Surg; 2023 Jan; 23(1):25. PubMed ID: 36709302
[TBL] [Abstract][Full Text] [Related]
37. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
38. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.
Muñoz A; Ay C; Grilz E; López S; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Ortega L; Rupérez A; Salas E; Pabinger I; Soria JM
J Clin Oncol; 2023 Jun; 41(16):2911-2925. PubMed ID: 36730884
[TBL] [Abstract][Full Text] [Related]
39. Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer.
Lei H; Tao D; Zhang N; Sun M; Sun L; Yang D; Jiang Y; Zhou W; Xie Y; Wang Y
Cancer Cell Int; 2023 Mar; 23(1):40. PubMed ID: 36872336
[TBL] [Abstract][Full Text] [Related]
40. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
